News about Global Pharma

Adragos Pharma Acquires Baccinex to Expand its Sterile Manufacturing Services

The acquisition of Baccinex aligns seamlessly with Adragos’ strategy to build a world-class manufacturing network that provides tailored solutions to meet the evolving needs of its customers.

Global Pharma | 28/11/2024 | By Aishwarya |  306

Freudenberg to Showcase Pioneering Solutions at CPHI & PMEC 2024

Freudenberg Medical recently announced the PharmaFocus Premium ASTC UV-Shield Tubing, which is specifically intended for photosensitive pharmaceuticals and has a platinum-cured silicone interior and an opaque exterior to maintain the integrity and stability of light-sensitive fluids.

Global Pharma | 26/11/2024 | By Aishwarya |  362

Lonza Completes its First GMP Batch of Next-Gen Mammalian Manufacturing Facility in US

The first GMP batch release marks a significant milestone, allowing the facility to help meet the increasing market demand for small- to mid-scale volumes of mammalian-derived biologics and support the implementation of high-titer and high-throughput platform processes.

Global Pharma | 25/11/2024 | By Aishwarya |  518

Johnson & Johnson Submits FDA Approval for SC Induction Regimen of TREMFYA in Ulcerative Colitis

TREMFYA® is the first and only approved, dual-acting monoclonal antibody that blocks IL-23 while also binding to CD64, a receptor on cells that produce IL-23.

Global Pharma | 25/11/2024 | By Aishwarya |  303

Syntegon Hits New Milestone in Sustainability with SBTi Validation

The validation confirms that Syntegon’s sustainability targets are in line with the 1.5°C goal.

Global Pharma | 22/11/2024 | By Aishwarya |  271

Pii Announces Investment of USD 3.6 Million to Expand PFS Services

Driven by the rising demand for prefilled syringe solutions in the pharmaceutical and biotech industries, Pii’s investment includes a state-of-the-art Optima syringe labeler and Antares automated visual inspection (AVI) system.

Global Pharma | 21/11/2024 | By Aishwarya |  522

Ractigen Therapeutics Secures FDA Orphan Drug Designation for RAG-21

RAG-21 is an siRNA therapy specifically designed to target FUS-ALS, one of the most aggressive subtypes of ALS.

Global Pharma | 20/11/2024 | By Aishwarya |  639

Samsung Biologics Announces Manufacturing Deal with European Pharmaceutical Company

Samsung Biologics is set to add antibody-drug conjugate (ADC) services to its portfolio, with a dedicated facility to be completed by the end of this year.

Global Pharma | 20/11/2024 | By Aishwarya |  387

NRx Pharmaceuticals Welcomes Michael Abrams as Chief Financial Officer

Abrams succeeds Interim-CFO Richard Narido, who will continue to support the Company's financial function and other projects.

Global Pharma | 19/11/2024 | By Aishwarya |  365

Telix Plans to Add FAP-Targeting Candidates to Theranostic Pipeline

Telix has entered into asset purchase and exclusive worldwide in-licence agreements for a suite of clinically validated FAP-targeting therapeutic and precision medicine (diagnostic) radiopharmaceutical candidates.

Global Pharma | 19/11/2024 | By Aishwarya |  639